ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Solana Beach, CA, US. The stock last traded at $14.83, up 1.51% on the session, giving a market capitalisation of $444.7M. On trailing twelve-month figures it carries a trailing P/E of -12.57, a net margin of -81.8%. Its beta of 1.27 implies it has historically moved more than the broad market.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
ClearPoint Neuro, Inc. is most often compared with the following Healthcare names: